Lists of pharmaceutical industry topics
The pharmaceutical industry is a sector that discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications. Pharmaceutical companies may deal in generic or brand medications and medical devices.
Drug Discovery and Development[edit | edit source]
Drug discovery and development is a complex process that involves biotechnological and pharmacological research to find new compounds with therapeutic potential.
Preclinical Research[edit | edit source]
Preclinical research is the phase where compounds are tested in vitro and in vivo to determine if they could become viable medications. This includes absorption, distribution, metabolism, and excretion (ADME) studies, toxicological testing, and pharmacodynamics and pharmacokinetics analysis.
Clinical Trials[edit | edit source]
Clinical trials involve multi-phase, systematic studies that include human subjects to test whether new drugs or treatments are safe and effective. Phases include:
- Phase I: Testing on healthy volunteers for safety and dosage.
- Phase II: Studies on patients to assess efficacy and side effects.
- Phase III: Large-scale testing for safety, efficacy, and comparison with standard or equivalent treatments.
- Phase IV: Post-marketing studies to delineate additional information including the drug's risks, benefits, and optimal use.
Regulation[edit | edit source]
The regulation of pharmaceuticals varies by jurisdiction but typically involves a Drug Regulatory Authority such as the FDA in the United States or the EMA in Europe, which oversee the approval of new drugs and monitor drug safety.
Market[edit | edit source]
The pharmaceutical market is influenced by a number of factors including patents, generic drugs, and pricing. Key topics include:
- Patent Protection and Exclusivity: Legal protections that provide a temporary monopoly on a new drug.
- Generics and Biosimilars: Versions of brand-name drugs that are allowed after patents expire.
- Pricing and Reimbursement: How drugs are priced and paid for by health systems and individuals.
Ethical Considerations[edit | edit source]
The pharmaceutical industry faces various ethical considerations, including marketing practices, the impact of drug pricing on access to medications, and the ethical conduct of clinical trials.
Future of the Pharmaceutical Industry[edit | edit source]
Advancements in personalized medicine, Biopharmaceuticals, and Digital Health are transforming the industry, alongside the challenges of global Pandemics and Antibiotic Resistance.
List of Pharmaceutical Industry Related Topics[edit | edit source]
- 340B Drug Pricing Program
- 3D drug printing
- 3D printed medicine
- 5-HT2C receptor agonist
- 5-HT3 antagonist
- AMNOG
- AbbVie
- Academy of Managed Care Pharmacy
- Accelerated approval (FDA)
- Access to Medicine Index
- Accredo
- Actelion
- Adebayo Alonge
- Adexa
- Adverse event
- Aging Research and Drug Discovery
- Agustín Tellería Mendizábal
- Air shower (room)
- Airlock
- Ajit Shetty
- Alex Azar
- Alex Gorsky
- Alexei Kharitonenkov
- Alexion Pharmaceuticals
- Align Biopharma
- Allen Chao
- Allen McClay
- Allion Healthcare
- America and its Hidden Victims
- American Association of Colleges of Pharmacy
- American Association of Psychiatric Pharmacists
- American College of Clinical Pharmacy
- American Pharmacists Association
- American Society for Pharmacy Law
- American Society of Consultant Pharmacists
- American Society of Health-System Pharmacists
- Amgen
- Amicus Therapeutics
- Anabaseine
- Andrew Witty
- Angiokinase inhibitors
- Animal efficacy rule
- Annual pharmaceutical drug sales
- Antitarget
- Apothecaries' Hall of Ireland
- Applicability domain
- Approved drug
- Arie Belldegrun
- Arthur D. Levinson
- Artificial intelligence in pharmacy
- Arven Pharmaceuticals
- Assay sensitivity
- Association for Accessible Medicines
- Association of the British Pharmaceutical Industry
- AstraZeneca
- Authorized generics
- Average wholesale price
- BIOVIA
- BUKO Pharma-Kampagne
- Bacterial therapy
- Bad Pharma
- Bangladesh Pharmaceutical Society
- Bausch Health
- Baxter International
- Bayer
- Bcr-Abl tyrosine-kinase inhibitor
- Beacon Pharmaceuticals
- Benzer Pharmacy
- Bernhard Joos
- Bevacizumab
- Big Pharma (book)
- Big Pharma conspiracy theories
- Bio Process Systems Alliance
- BioMarin Pharmaceutical
- BioPharm Systems
- Biodollars
- Biogen
- Biologics license application
- Biomanufacturing
- Biomedical Systems
- Biomedical text mining
- Biopharmaceutical
- Biosplice Therapeutics
- Biotechnology in pharmaceutical manufacturing
- Biotechnology industry in Italy
- Björgólfur Thor Björgólfsson
- Black triangle (pharmacovigilance)
- Blow fill seal
- Board of Pharmacy Specialties
- Boris Spiegel
- Botanical drug
- Boxed warning
- Brandon Colby
- Bristol Myers Squibb
- British Generic Manufacturers Association
- Bundesverband der Pharmazeutischen Industrie
- Busulfan
- CCR5 receptor antagonist
- COVID-19 drug development
- CVS Health
- Camfil
- Canadian Pharmacists Association
- Canadian Society of Hospital Pharmacists
- Cannabinoid receptor antagonist
- Capecitabine
- Capsule (pharmacy)
- Case report form
- Catalyst Pharmaceuticals
- Cel-Sci Corporation
- Celgene
- Center for Pharmaceutical Research and Innovation
- Certificate of pharmaceutical product
- Chaleo Yoovidhya
- Chemaxon
- Chemical library
- Chemical similarity
- Cheminformatics
- Chemogenomics
- Chris Gent
- Christine Meeusen
- Christopher A. Lipinski
- Christopher Evans (businessman)
- Chugai Pharmaceutical Co.
- Classical pharmacology
- Claude H. Nash
- Cleanliness suitability
- Cleanroom
- Cleanroom suit
- ClearTrial
- Clinical Data Interchange Standards Consortium
- Clinical Practice Research Datalink
- Clinical data acquisition
- Clinical data management
- Clinical data management system
- Clinical research coordinator
- Clinical trial
- Clinical trial management system
- Co-pay card
- Cold chain
- Combinatorial chemistry
- Common Technical Document
- Company Chemists' Association
- Complete Response Letter
- Compound management
- Conflict of interest in the healthcare industry
- Consumer Healthcare Products Association
- Consumer import of prescription drugs
- Contamination control
- Contract manufacturing organization
- Contract research organization
- Core outcome set
- Corporate Crime in the Pharmaceutical Industry
- Corrective and preventive action
- Cost of HIV treatment
- Cost of drug development
- Council of the College of Pharmacists of Chile
- Counterfeit medications
- Covington & Burling
- Critical Path Institute
- Critical process parameters
- Cyrus Tang
- DNA-encoded chemical library
- Daniel Vasella
- Danish Association of Pharmaconomists
- Data clarification form
- Data monitoring committee
- David Ebsworth
- David Meek
- De-linkage
- Dean Y. Li
- Dechert
- Delcath Systems
- Derek Lowe (chemist)
- Derwent Drug File
- Design space verification
- Didier de Chaffoy de Courcelles
- Dilution assay
- Diplomat Pharmacy
- Direct-to-consumer advertising
- Dirty drug
- Disease mongering
- Dissolution testing
- Docking (molecular)
- Dona Bertarelli
- Donald L. Drakeman
- Donald Rumsfeld
- Downstream processing
- Drug Industry Documents Archive
- Drug Master File
- Drug Price Competition and Patent Term Restoration Act
- Drug coupon
- Drug design
- Drug development
- Drug discovery
- Drug nomenclature
- Drug packaging
- Drug repositioning
- Druggability
- Druglikeness
- Dublin Molecular Medicine Centre
- Dynamic combinatorial chemistry
- E. R. Squibb
- EMBiology
- Edward Mead Johnson
- Effect size
- Einar W. Sissener
- Electronic common technical document
- Electronic data capture
- Electronic patient-reported outcome
- Eli Hurvitz
- Eli Lilly and Company
- Elizabeth Fagan
- Elmer Holmes Bobst
- Emil Steen (1870–1915)
- Environmental impact of pharmaceuticals and personal care products
- Environmental persistent pharmaceutical pollutant
- Epedigree
- Epitopoietic Research Corporation
- Ernest Mario
- Ernesto Bertarelli
- Ernst Christian Friedrich Schering
- Ernő Duda
- Eroom's law
- EudraCT
- European Federation of Pharmaceutical Industries and Associations
- European Forum for Good Clinical Practice
- European Pharmaceutical Students' Association
- Eva Steiness
- Ewing Kauffman
- Excipient
- Expert Opinion on Therapeutic Patents
- Express Scripts
- FED-STD-209E
- Federal Agency for Medicines and Health Products
- Fill and finish
- Fire in the Blood (2013 film)
- First Databank
- Fish & Richardson
- Fitch, Even, Tabin & Flannery
- Fragment-based lead discovery
- Frank J. Mrvan
- Fred Hassan
- Frederik Paulsen Jr
- Frederik Paulsen Sr
- Fredrik Steen
- Functional Assessment of Cancer Therapy - General
- G. Raymond Rettew
- GABAA receptor positive allosteric modulator
- GSK plc
- Ge Li
- Gedeon Richter (company)
- Genentech
- Generic drug
- Generic pharmaceutical price decay
- Genzyme
- George J. Seabury
- George Rosenkranz
- George W. Merck
- Gilead Sciences
- Glycorandomization
- Good automated manufacturing practice
- Good clinical data management practice
- Good clinical practice
- Good documentation practice
- Good manufacturing practice
- Goodwin Procter
- Granulation
- Groundwater contamination by pharmaceuticals
- Gus Attridge
- Günther Friedländer
- HEPA
- Haim Aviv
- Harry Jephcott
- Harsh Goenka
- Healthcare Distribution Association
- Healthy Skepticism
- Henry C. Davis
- Henry Wellcome
- Herbert Boyer
- High-content screening
- High-throughput screening
- Hiroaki Suga
- History of general anesthesia
- History of neuraxial anesthesia
- History of pharmacy
- Hit selection
- Hit to lead
- Human decontamination
- ISO 14644
- ISO 14698
- Ian Read
- IdMOC
- Immunomodulatory imide drug
- In silico
- Inclusion and exclusion criteria
- Indian Pharmaceutical Alliance
- Industrial fermentation
- Industry Documents Library
- Influenza Antiviral Drug Search
- Information Services Division
- Innovative Medicines Canada
- Innovative Medicines Initiative
- Institute of Environmental Sciences and Technology
- Insulated shipping container
- Interferon beta-1a
- International Federation of Pharmaceutical Manufacturers & Associations
- International Pharmaceutical Excipients Council
- International Pharmaceutical Federation
- International Pharmaceutical Students' Federation
- Inverse benefit law
- Investigational device exemption
- Isomorphic Labs
- Isostere
- Jacques Biot
- James E. Burke
- James Wood Johnson
- Japan Pharmaceutical Association
- Japan Pharmaceutical Manufacturers Association
- Jean-Pierre Garnier
- Jeffery W. Kelly
- Jerome Carle
- Jimi Agbaje
- John Emory Andrus
- John K. Smith
- John M. Gregory (businessman)
- John Ripley Myers
- Johnson & Johnson
- Jonah Shacknai
- Joseph Beecham
- Judith Giuliani
- Kenyon & Kenyon
- Kevin Slawin
- Kevin W. Sharer
- Kirovs Lipmans
- Korea Pugang Corporation
- Kostyantyn Efymenko
- Laminar flow
- Laminar room
- Latent semantic structure indexing
- LeDock
- Lead compound
- Ligand efficiency
- Liminal BioSciences
- Linklaters
- Lipinski's rule of five
- Lipophilic efficiency
- List of cheminformatics toolkits
- List of countries by pharmaceutical exports
- List of drugs by year of discovery
- List of pharmaceutical companies
- List of pharmacy associations
- Lists of pharmaceutical industry topics
- Living medicine
- Lloyd Huck
- Lunsford Richardson
- MTOR inhibitors
- Mahlon Kline
- Mark Fishman
- Marketing authorisation
- Masaji Kitano
- Matthew Mirones
- Me-too drug
- Mean kinetic temperature
- Median price ratio
- Medicago Inc.
- Medical Products Agency (Sweden)
- Medical science liaison
- Medicare Prescription Drug Price Negotiation Act
- Medication
- Medication costs
- Medication package insert
- Medicines and Medical Devices Agency of Serbia
- Medidata Solutions
- Medivir
- Melatonin receptor agonist
- Melphalan
- Merck & Co.
- Merck family
- Metalloprotease inhibitor
- Mexican barbasco trade
- Michael C. Heim
- Michael Smith (chemist)
- Microextrusion
- Mike Ross (politician)
- Minor Use Animal Drug Program
- Moisture sorption isotherm
- Moisture vapor transmission rate
- Molecular phenotyping
- Monitoring in clinical trials
- Multicenter trial
- Mérieux family
- NK1 receptor antagonist
- NMDA receptor
- National Average Drug Acquisition Cost
- National Environmental Balancing Bureau
- National Institute for Pharmaceutical Technology & Education
- National Pharmacy Association
- Nettie Leila Michel
- New Drug Application
- New chemical entity
- Newhouse Research Site
- Nicotinic agonist
- Nimmagadda Prasad
- Nocebo
- Non-contact wafer testing
- Nonconformity (quality)
- Norwegian Pharmacy Association
- Novartis
- Novo Nordisk
- Number needed to harm
- Number needed to treat
- Obi Peter Adigwe
- Omnicare
- Onasemnogene abeparvovec
- Onyx Pharmaceuticals
- Open flow microperfusion
- OpenPHACTS
- Orphan drug
- Osmotic-controlled release oral delivery system
- P. Roy Vagelos
- PDUFA date
- PFIs
- Pakistan Pharmacists Association
- Palbociclib
- Pankaj Patel
- Param Singh (consultant)
- Parenteral Drug Association
- Patient diary
- Patient recruitment
- Patient-reported outcome
- Patrick Soon-Shiong
- Paul Le Roux
- Perspective (pharmacoeconomic)
- Peter Koo
- Peter R. Dolan
- Peter S. Kim
- Pfizer
- Pharma fraud
- Pharmaceutical Accountability Foundation
- Pharmaceutical Association of Israel
- Pharmaceutical Association of Mauritius
- Pharmaceutical Group of the European Union
- Pharmaceutical Research and Manufacturers of America
- Pharmaceutical Society of Ireland
- Pharmaceutical Society of New Zealand
- Pharmaceutical Society of Nigeria
- Pharmaceutical bioinformatics
- Pharmaceutical distribution
- Pharmaceutical engineering
- Pharmaceutical fraud
- Pharmaceutical industry
- Pharmaceutical industry in Bangladesh
- Pharmaceutical industry in Romania
- Pharmaceutical industry in Russia
- Pharmaceutical industry in Switzerland
- Pharmaceutical innovations
- Pharmaceutical lobby
- Pharmaceutical manufacturing
- Pharmaceutical marketing
- Pharmaceutical medicine
- Pharmaceutical sales representative
- Pharmacists for Life International
- Pharmacoeconomics
- Pharmacoinformatics
- Pharmacometrics
- Pharmaconomist
- Pharmacyclics
- Pharmapod
- Pharming (genetics)
- Phenotypic screening
- Phosphoinositide 3-kinase inhibitor
- Photoalignment
- Pill Prizes
- Plascore Incorporated
- Portola Pharmaceuticals
- Portuguese Pharmaceutical Industry Association
- Precision BioSciences
- Preclinical development
- Prescription drug prices in the United States
- Prescription monitoring program
- Prescriptive authority for psychologists movement
- Prioritization
- Process analytical technology
- Process performance qualification protocol
- Project 523
- Protein mimetic
- Protide
- Psychedelic therapy
- Quantitative structure–activity relationship
- R-Pharm
- RAJ Pharma
- RNA-targeting small molecule drugs
- Ralph S. Larsen
- Rebecka Belldegrun
- Remote data capture
- Remote data entry
- René Soetens
- Research chemical
- Retro screening
- Retrometabolic drug design
- Reverse pharmacology
- Richard Clark (business executive)
- Richard DiMarchi
- Rituximab
- Robert A. Bradway
- Robert A. Swanson
- Robert S. Langer
- Robert Wood Johnson I
- Robert Wood Johnson II
- Robert Wood Johnson III
- Roche
- Roger M. Perlmutter
- Ronald Plasterk
- Ropes & Gray
- Russell Earl Marker
- SAMPL Challenge
- SEMATECH
- Safety monitoring
- Samih Darwazah
- Samuel D. Waksal
- Sanatogen
- Sangamo Therapeutics
- Sanofi
- Sarepta Therapeutics
- Scioderm
- Scottish Intercollegiate Guidelines Network
- Scrip World Pharmaceutical News
- Seeding trial
- Semiconductor device fabrication
- Serious adverse event
- Shire (pharmaceutical company)
- Sidney Taurel
- Silas M. Burroughs (pharmacist)
- Simmons & Simmons
- Simon Roberts (businessman)
- Sinecatechins
- Sink condition
- Site Master File
- Small molecule
- Sodium thiosulfate
- Sofosbuvir
- Solidarity trial
- Source document
- Southern Research
- Specialty drugs in the United States
- Specialty pharmacy
- Spectrum Pharmaceuticals
- Spray drying
- Stability testing (pharmaceutical)
- Standard operating procedure
- Standard treatment
- Stanley Adams (whistleblower)
- Statisticians in the Pharmaceutical Industry
- Stephen Saad
- Steroidal aromatase inhibitor
- Stevanato Group
- Stewart Gregory
- Sticky mat
- Stromagen
- Suhon Lin
- Sumitomo Pharma America, Inc.
- TNO intestinal model
- Tablet (pharmacy)
- Tablet press
- Tagg Romney
- Takeda Pharmaceutical Company
- Target 2035
- Target protein
- Targeted drug delivery
- The Pharmacy Guild of Australia
- Theodor Sproll
- Therapy
- Thomas Beecham (chemist)
- Tigers (2014 film)
- Tilray
- Title 21 CFR Part 11
- Tom McKillop
- Track and trace
- Trastuzumab
- Tufts Center for the Study of Drug Development
- Tumor-homing bacteria
- UCSF Library
- Ultra-low particulate air
- UniFirst
- Unidimensional Fatigue Impact Scale
- Universal flu vaccine
- Utako Okamoto
- Vaccine ingredients
- Validation (drug manufacture)
- Validation master plan
- Vaxart
- Venoms in medicine
- Verastem Oncology
- Verband Forschender Arzneimittelhersteller
- Verification and validation
- Verne M. Willaman
- Vertex Pharmaceuticals
- Vietnamese Pharmaceutical Association
- ViiV Healthcare
- ViroPharma
- Virtual screening
- Vladimir Bryntsalov
- Walgreens Boots Alliance
- Wensley Haydon-Baillie
- Wholesale acquisition cost
- William McLaren Bristol
- Willis Whitfield
- Wilmer Cutler Pickering Hale and Dorr
- Wilson Therapeutics
- Woody Johnson
- Worshipful Society of Apothecaries
- Xiaodong Wang (biochemist)
- Yusuf Hamied
- Yvonne Greenstreet
- Z-factor
- Zalcitabine
- Zhong Shanshan
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD